How to face 3 common private practice hassles
Actionable resources, professional autonomy and banding together when needed give private-practice physicians the power to alleviate common headaches.
Quick Take: Moves cut barriers to opioid-use disorder treatment
In actions that will save lives, New Jersey and Washington, D.C., removed prior authorization for Medicaid patients who need medication-assisted treatment.
District of Columbia takes important step to reverse opioid epidemic
The MSDC and the AMA applauded the mayor’s office for removing prior authorization for medications to treat opioid use disorder.
AMA: New Jersey shows leadership to help end opioid epidemic
The AMA commended NJ Gov. Murphy and state Human Services Commissioner Johnson for helping end barriers to treatment for patients with opioid use disorder.
Physicians score overwhelming victory in bid to fix prior authorization
Stories, data on patient impact carried the day with legislators, who mandated that insurers respond to all urgent prior authorization requests within a day.
Health insurance industry slow to adopt prior authorization reforms
Despite potentially harmful consequences of delayed care, health plans not making progress reforming prior authorization process they impose on patient care.
Insurers’ progress on fixing prior authorization is disappointingly slow
Despite the potential patient harm posed by health plan prior authorization requirements, little meaningful progress has been made to reform the process.
AMA and CMA praise Atty. Gen. Becerra for supporting MAT
American Medical Association, California Medical Association praise California attorney general call for helping patients struggling with substance use disorder.
Life-saving treatment bill advanced in state hit hard by opioid epidemic
Kentucky becomes latest state taking action to remove “senseless” insurance company barriers to opioid-use disorder treatment.